These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 25545238)

  • 1. Modeling of the pharmacokinetic/pharmacodynamic interaction between irbesartan and hydrochlorothiazide in normotensive subjects.
    Hedaya MA; Helmy SA
    Biopharm Drug Dispos; 2015 May; 36(4):216-31. PubMed ID: 25545238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and pharmacodynamic interaction between irbesartan and hydrochlorothiazide in renal hypertensive dogs.
    Huang XH; Qiu FR; Xie HT; Li J
    J Cardiovasc Pharmacol; 2005 Dec; 46(6):863-9. PubMed ID: 16306814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic properties and bioequivalence of two irbesartan/ hydrochlorothiazide fixed-dose combination tablets in healthy male Chinese volunteers.
    Liu J; Wu L; Hu X; Wu G; Zheng Y; Zhou H; Zhai Y; Zhu M; ShenTu J
    Int J Clin Pharmacol Ther; 2015 Jul; 53(7):573-81. PubMed ID: 25828636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PK-PD modeling of irbesartan in healthy Chinese adult volunteers under non-steady-state conditions.
    Huang XH; Li J; Qiu FR; Xie HT; Huang JH; Li JC; Zheng QS
    Eur J Drug Metab Pharmacokinet; 2006; 31(4):259-64. PubMed ID: 17315536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic interactions of valsartan and hydrochlorothiazide: an open-label, randomized, 4-period crossover study in healthy Egyptian male volunteers.
    Hedaya MA; Helmy SA
    Clin Ther; 2013 Jun; 35(6):846-61. PubMed ID: 23795576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irbesartan and hydrochlorothiazide association in the treatment of hypertension.
    Derosa G; Ferrari I; Cicero AF
    Curr Vasc Pharmacol; 2009 Apr; 7(2):120-36. PubMed ID: 19355995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and tolerability of fixed-dose irbesartan/hydrochlorothiazide for rapid control of severe hypertension.
    Neutel JM; Franklin SS; Bhaumik A; Lapuerta P; Oparil S
    Clin Exp Hypertens; 2009 Oct; 31(7):572-84. PubMed ID: 19886855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of Single and Multi Dose Treatment of Glipizide on Pharmacokinetics and Pharmacodynamics of Irbesartan in Normal and Hypertensive Rats.
    Anusha A; Narendar D; Krishna Murthy B; Goverdhan P
    High Blood Press Cardiovasc Prev; 2017 Jun; 24(2):179-185. PubMed ID: 28386752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics (PK/PD) of irbesartan in Beagle dogs after oral administration at two dose rates.
    Carlucci L; Song KH; Yun HI; Park HJ; Seo KW; Giorgi M
    Pol J Vet Sci; 2013; 16(3):555-61. PubMed ID: 24195292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacodynamics of irbesartan in healthy subjects.
    Marino MR; Langenbacher K; Ford NF; Uderman HD
    J Clin Pharmacol; 1998 Mar; 38(3):246-55. PubMed ID: 9549663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative bioavailability of two irbesartan/hydrochlorothiazide tablet formulations in Indonesian healthy subjects.
    Sasongko L; Harahap Y; Prasaja B; Lusthom W; Setiawan EC; Meliala RS; Lipin
    Arzneimittelforschung; 2010; 60(12):749-53. PubMed ID: 21265466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. I-ADD study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with irbesartan monotherapy in hypertensive patients uncontrolled with irbesartan 150 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study.
    Bobrie G;
    Clin Ther; 2012 Aug; 34(8):1720-34.e3. PubMed ID: 22853847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Investigations of the antihypertensive long-term action of candesartan cilexetil in different dosages under the influence of therapy-free intervals].
    Weisser B; Gerwe M; Braun M; Funken C
    Arzneimittelforschung; 2005; 55(9):505-13. PubMed ID: 16229114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiologically Based Pharmacokinetic Modeling of Fimasartan, Amlodipine, and Hydrochlorothiazide for the Investigation of Drug-Drug Interaction Potentials.
    Rhee SJ; Lee HA; Lee S; Kim E; Jeon I; Song IS; Yu KS
    Pharm Res; 2018 Oct; 35(12):236. PubMed ID: 30324316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of a fixed combination of irbesartan/hydrochlorothiazide in Chinese patients with moderate to severe hypertension.
    Huang QF; Sheng CS; Li Y; Ma GS; Dai QY; Wang JG;
    Drugs R D; 2013 Jun; 13(2):109-17. PubMed ID: 23605903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic and pharmacodynamic interaction of single doses of valsartan and atenolol.
    Czendlik CH; Sioufi A; Preiswerk G; Howald H
    Eur J Clin Pharmacol; 1997; 52(6):451-9. PubMed ID: 9342580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Irbesartan in clinical practice].
    Malishevskiĭ MV
    Kardiologiia; 2012; 52(11):66-74. PubMed ID: 23237398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioequivalence studies for 2 different strengths of irbesartan/hydrochlorothiazide combination in healthy volunteers: 300/25 mg and 300/12.5 mg film-coated tablets.
    Cánovas M; Cabré F; Polonio F
    Drug Res (Stuttg); 2014 May; 64(5):257-62. PubMed ID: 24105103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Observational study of blood pressure control and microalbuminuria in type 2 diabetics on irbesartan or irbesartan/HCTZ].
    Schmieder RE; Krekler M
    MMW Fortschr Med; 2005 Oct; 147 Suppl 3():97-101. PubMed ID: 16261944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human pharmacokinetic/pharmacodynamic profile of irbesartan: a new potent angiotensin II receptor antagonist.
    Ruilope L
    J Hypertens Suppl; 1997 Dec; 15(7):S15-20. PubMed ID: 9532516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.